Fischer Medical Ventures Ltd (FISCHER) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Fischer Medical

J.G.Chemicals

I G Petrochems

GHCL

Blue Pearl Agri

TruAlt Bioenergy

Gujarat Alkalies

Grauer & Weil

Amines & Plast.

Tanfac Inds.

Thirumalai Chem.

Why is Fischer Medical Ventures Ltd ?

Poor Management Efficiency with a low ROE of 5.57%

The company has been able to generate a Return on Equity (avg) of 5.57% signifying low profitability per unit of shareholders funds

With ROE of 5.6, it has a Very Expensive valuation with a 6.1 Price to Book Value

Over the past year, while the stock has generated a return of -58.59%, its profits have fallen by -20%

Falling Participation by Institutional Investors

Institutional investors have decreased their stake by -0.81% over the previous quarter and collectively hold 6.22% of the company
These investors have better capability and resources to analyse fundamentals of companies than most retail investors

Underperformed the market in the last 1 year

Even though the market (BSE500) generated negative returns of -3.31% in the last 1 year, its fall in the stock was much higher with a return of -58.59%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Commodity Chemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Fischer Medical for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Fischer Medical

-58.59%

-1.03

57.02%

Sensex

-5.47%

-0.43

12.65%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

427.60%

EBIT Growth (5y)

0.60%

EBIT to Interest (avg)

9.56

Debt to EBITDA (avg)

9.13

Net Debt to Equity (avg)

-0.04

Sales to Capital Employed (avg)

0.27

Tax Ratio

21.79%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

6.22%

ROCE (avg)

1.92%

ROE (avg)

5.57%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

6.07

EV to EBIT

51.71

EV to EBITDA

48.75

EV to Capital Employed

6.26

EV to Sales

8.36

PEG Ratio

Dividend Yield

ROCE (Latest)

6.10%

ROE (Latest)

5.57%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

37What is working for the Company

NET SALES(Q)

At Rs 101.10 cr has Grown at 136.9% (vs previous 4Q average

PAT(Q)

At Rs 19.23 cr has Grown at 283.7% (vs previous 4Q average

PBDIT(Q)

Highest at Rs 21.57 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 21.34%

PBT LESS OI(Q)

Highest at Rs 20.10 cr.

EPS(Q)

Highest at Rs 0.30

-1What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Fischer Medical

Net Sales - Quarterly

At Rs 101.10 cr has Grown at 136.9% (vs previous 4Q average)

over average Net Sales of the previous four quarters of Rs 42.67 Cr

MOJO Watch

Near term sales trend is very positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 20.10 cr has Grown at 321.2% (vs previous 4Q average)

over average PBT of the previous four quarters of Rs 4.77 Cr

MOJO Watch

Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 19.23 cr has Grown at 283.7% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs 5.01 Cr

MOJO Watch

Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly

Highest at Rs 21.57 cr. and Grown

each quarter in the last five quarters

MOJO Watch

Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly

Highest at 21.34% and Grown

each quarter in the last five quarters

MOJO Watch

Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly

Highest at Rs 20.10 cr. and Grown

each quarter in the last five quarters

MOJO Watch

Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

Highest at Rs 19.23 cr. and Grown

each quarter in the last five quarters

MOJO Watch

Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly

Highest at Rs 101.10 cr

in the last five quarters

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Earnings per Share (EPS) - Quarterly

Highest at Rs 0.30

in the last five quarters

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)